关于补充系统和认知障碍的研究进展
Jie Gao1, Zhe Li1, Xinyue Zhang1
1Department of Anesthesiology, the First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang 110001, Liaoning Province, China.
Immunobiology
|January 14, 2026
概括
认知障碍与补体系统和神经炎症有关. 了解这种联系可能会导致针对认知功能障碍的补体系统的新疗法.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 认知障碍是一个重大的全球健康挑战,患病率和死亡率不断上升.
- 补体系统越来越多地被认为在潜在的认知功能障碍的病理过程中发挥着关键作用.
- 神经炎症是认知障碍发展的关键因素,补充系统与其进展有关.
研究的目的:
- 在认知障碍的背景下阐明补充系统和神经炎症之间的复杂关系.
- 探索补充系统为认知功能障碍做出贡献的机制.
- 审查补充抑制剂作为改善和预防认知障碍的治疗策略的潜力.
主要方法:
- 本综述综合了关于补充系统在神经炎症和认知衰退中的作用的当前研究.
- 它检查了补充系统的生理功能.
- 该审查分析了将补充激活与认知功能障碍联系在一起的机制,并评估了有针对性的治疗方法.
主要成果:
- 补体系统本质上与驱动认知障碍的神经炎症过程有关.
- 补充系统中的特定途径对神经元损伤和认知缺陷有重大贡献.
- 有证据表明,调节补充活性可以影响认知功能障碍的轨迹.
结论:
- 准补充系统为管理认知障碍提供了一个有希望的治疗途径.
- 为了开发有效的治疗方法,对补充抑制剂的进一步研究是有必要的.
- 对补充介导的神经炎症的全面理解对于推进认知健康策略至关重要.
相关概念视频
Complement System
9.8K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
9.8K
Cognitive Development During Adulthood
780
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
780
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
560
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
560
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Cognitivism
2.9K
Cognitive psychology emerged as a significant field in the mid-20th century. It focused on understanding humans' internal mental processes. This approach emphasizes how people perceive, remember, think, and solve problems—elements critical to human cognition.
Previously dominated by behaviorism, which prioritized observable behaviors and largely ignored mental processes, psychology transformed in the 1950s. Cognitive psychologists argue that understanding how we think and process...
Previously dominated by behaviorism, which prioritized observable behaviors and largely ignored mental processes, psychology transformed in the 1950s. Cognitive psychologists argue that understanding how we think and process...
2.9K
Alzheimer's Disease: Treatment
824
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
824


